Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Guggenheim ...

Novo Nordisk isn't in the Vanguard Healthcare ETF because it is a Danish company, and the fund focuses on U.S. companies. The ETF would be down even more if it included Novo Nordisk since the company ...

Pfizer recently recalibrated its evaluation score, a nod to shifting trends in the market and its own financial pulse. The ...

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...

Pfizer Inc. (NYSE:PFE) hasn’t performed well in recent years, with its stock declining more than 26% over the past decade.

A look at the shareholders of Pfizer Inc. (NYSE:PFE) can tell us which group is most powerful. The group holding the most ...

Merck & Co., Inc. outshines Gilead Sciences, Inc. with stronger dividend growth, valuation metrics & PEGY ratio. Click for ...

Shares of Johnson & Johnson climbed 4.5% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for the biggest one-day gain since they rallied 4.6% on May 1, 2024.

These are three rock-solid dividend stocks you can buy now and confidently forget, knowing they’ll keep working for you year ...

Amgen combines patent protection, a robust pipeline, and strong execution for defensive investment. Click here to read an ...

As different stocks rise and fall, so do dividend yields, creating a shifting landscape of opportunities for income-oriented investors. Increases in dividend per share (DPS) greatly allow companies to ...